Revolution Medicines, Inc.

http://revolutionmedicines.com/

Last activity: 01.05.2026

Active - Reference to REVOLUTION Medicines

Mentions

Overview

Employees

51-200

Total raised

$170M

Founded date

2014

Funding Rounds 3

Date	Series	Amount	Investors
Sign up to see	Sign up to see	Sign up to see	Sign up to see
Dec 20, 2016	Series A round	$25M
Feb 4, 2015	Series A round	$45M

Mentions in press and media 15

Date	Title	Description
Sign up to see	Sign up to see	Sign up to see
Nov 12, 2025	AI-Driven Biotech Iambic Secures Over $100M for Drug Discovery	Iambic, a San Diego AI-driven biotech, secured over $100M in funding. This capital fuels its advanced AI drug discovery platform and expanding clinical pipeline. The company rapidly advances novel therapies, like IAM1363, showing strong ant...
Nov 10, 2025	Iambic: $100 Million Raised To Advance AI-Discovered Therapeutics And Platform Technologies	Iambic, a clinical-stage life science and technology company headquartered in San Diego, announced that it has raised more than $100 million in an oversubscribed financing round. The round drew participation from a broad group of new and ex...
Oct 17, 2025	Stocks making the biggest moves midday: Oracle, AST SpaceMobile, Revolution Medicines and more
Oct 16, 2025	Cramer’s Lighting Round: Hold Martin Marietta Materials	Monday - Friday, 6:00 - 7:00 PM ET It’s that time again! “Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed. TopBuild: “I would some trimming of that st...
Oct 16, 2025	Stocks close higher as bank credit worries, China trade tensions ease	The Dow Jones Industrial Average rose Friday as traders digested the U.S.′ softening tone on its trade talks with China and tried to move past credit concerns that sparked a big sell-off in regional banks Thursday. The Dow finished 238.37 p...
Jul 10, 2019	Revolution Medicines secures $100M equity round, aiming for hard-to-reach oncology targets	The company’s pipeline includes programs targeting the KRAS G12C pathway. While long considered undruggable due to the lack of sufficient “pockets” for pharmaceutical agents to penetrate, KRAS G12C was recently validated as a target thanks ...
Jul 9, 2019	Three Cancer Drug Developers Raise Big Rounds, Securing Over $500M	7 Shares Email Facebook Twitter LinkedIn In medical-related funding news, three companies focused on developing treatments, therapies and medicines for cancer patients have announced supergiant rounds. Subscribe to the Crunchbase Daily Acro...
Jul 9, 2019	Third Rock cancer startup Revolution Medicines scores $100M in fresh raise	Having swallowed fellow Third Rock-backed Warp Drive Bio’s oncology pipeline and wooed Sanofi $SNY on as a partner, Redwood City-based biotech Revolution Medicines has raised $100 million in a fresh round of funding. In 2017...
Jul 9, 2019	Revolution Medicines Closes $100M Financing	Revolution Medicines, Inc., a Redwood City, Calif.-based clinical-stage leader in the discovery and development of novel small molecule inhibitors of frontier oncology targets within notorious pathways, closed a $100m Series C equity financ...
Apr 24, 2018	Term Sheet — Tuesday, April 24	UBER’S PROMISES Good morning, Term Sheet readers. Paid Content You can't secure what you can't see From ExtraHop Last year, Uber released its diversity numbers for the first time since its inception in 2009. While it’s diversity numbers wer...
Dec 21, 2016	Term Sheet — Wednesday, December 21	OPEN MIC Good morning. Today I’m sharing your best macro and tech predictions for 2017. Paid Content You can't secure what you can't see From ExtraHop -“ Bond ETFs are not as safe nor liquid as advertised.” -“Trump proves to be a moderate, ...
Dec 20, 2016	Revolution Medicines Raises $25M in Series A Extension Financing	Revolution Medicines, Inc., a Redwood City, Calif.-based company focused on frontier cancer targets and drug discovery inspired by nature’s lessons, raised $25m in a Series A extension financing. The Column Group joined founding investor Th...
Feb 4, 2015	Revolution Medicines Raises $45M Series A Financing	Revolution Medicines, Inc., a Redwood City, CA-based newly formed developer of new therapies derived from natural products, raised $45m Series A financing. Third Rock Ventures, LLC, participated in the foundation and the funding of the comp...
	Revolution Medicines secures $100M equity round, aiming for hard-to-reach oncology targets	A firm developing drugs that target what it calls “notorious” pathways in oncology has raised a big round of equity financing. Redwood City, California-based Revolution Medicines said Tuesday that it had closed a $100 million Series C finan...

Reviews 0

FAQ about Revolution Medicines, Inc.

When was Revolution Medicines, Inc. founded?

Revolution Medicines, Inc. was founded in 2014.

How much funding has Revolution Medicines, Inc. raised?

Revolution Medicines, Inc. has raised $170M in total across 3 funding rounds.

What funding rounds has Revolution Medicines, Inc. raised?

Parsers VC lists 3 funding rounds of Revolution Medicines, Inc., among them a Series A round of $25M on Dec 20, 2016 and a Series A round of $45M on Feb 4, 2015.

What has the press written about Revolution Medicines, Inc.?

Parsers VC has collected 15 articles mentioning Revolution Medicines, Inc., among them “AI-Driven Biotech Iambic Secures Over $100M for Drug Discovery” (Nov 12, 2025) and “Iambic: $100 Million Raised To Advance AI-Discovered Therapeutics And Platform Technologies” (Nov 10, 2025).

Is Revolution Medicines, Inc. still active?

Yes, Revolution Medicines, Inc. is active; its latest activity on Parsers VC dates from May 1, 2026.